Hiroyuki Suzuki

40PUBLICATIONS
38CO-AUTHORS
GlycoconjugatesCancer diagnosisPredictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jul 24, 2026
A Novel Anti-Cadherin-17 Monoclonal Antibody, Ca17Mab-5, for Multiple Applications.

|May 27, 2026
Ca13Mab-17, a Novel Anti-Cadherin-13 Monoclonal Antibody for Versatile Applications.

|May 27, 2026
Chimeric Anti-Glypican 1 Antibodies Exert Antitumor Activities in Xenograft Models of Lung and Pancreatic Cancers.

|Apr 14, 2026
Antitumor Activities of Chimeric Anti-EphA2 Antibodies in Xenograft Models of Breast, Pancreatic, and Colorectal Cancers.

Guanjie Li, Hiroyuki Suzuki, Tomokazu Ohishi

|Mar 28, 2026
A Novel Anti-Cadherin-19 Monoclonal Antibody (Ca19Mab-8) for Flow Cytometry, Western Blotting, and Immunohistochemistry.

Guanjie Li, Hiroyuki Suzuki, Mika K Kaneko

|Dec 10, 2025
Therapeutic Potential of an Anti-CD44v6 Monoclonal Antibody in Xenograft Models of Colorectal and Gastric Cancer.

Aoi Hirayama, Tomohiro Tanaka, Tomokazu Ohishi

Pageof 7

Frequent Collaborators

38 joint publications

Yukinari Kato

24 joint publications

Mika K Kaneko

19 joint publications

Tomokazu Ohishi

7 joint publications

Teizo Asano